The role of the D3 dopamine receptor and its partial agonist cariprazine in patients with schizophrenia and substance use disorder
H Grunze - Expert Opinion on Pharmacotherapy, 2023 - Taylor & Francis
Introduction Comorbidity of substance use disorder (SUD) with schizophrenia, referred to as
dual disorder (DD), significantly increases morbidity and mortality compared to …
dual disorder (DD), significantly increases morbidity and mortality compared to …
Rethinking clozapine: lights and shadows of a revolutionary drug
L Dell'Osso, C Bonelli, B Nardi, F Giovannoni… - Brain Sciences, 2024 - mdpi.com
The current literature globally highlights the efficacy of Clozapine in several psychiatric
disorders all over the world, with an FDA indication for reducing the risk of repeated suicidal …
disorders all over the world, with an FDA indication for reducing the risk of repeated suicidal …
Association of clozapine treatment and rate of methamphetamine or amphetamine relapses and abstinence among individuals with concurrent schizophrenia …
R Rafizadeh, L Frankow, H Mahmood… - Journal of …, 2023 - journals.sagepub.com
Background: Preliminary evidence suggest clozapine is associated with more favorable
impact on concurrent substance use disorder related outcomes in patients with concurrent …
impact on concurrent substance use disorder related outcomes in patients with concurrent …
[HTML][HTML] Navigating the Complex Intersection of Substance Use and Psychiatric Disorders: A Comprehensive Review
A Bahji - Journal of Clinical Medicine, 2024 - mdpi.com
The co-occurrence of substance use disorders (SUDs) and psychiatric conditions, often
referred to as comorbidity or concurrent disorders, presents intricate challenges in both …
referred to as comorbidity or concurrent disorders, presents intricate challenges in both …
Investigating the effectiveness of brexpiprazole in subjects with schizophrenia spectrum illness and co-occurring substance use disorder: a prospective, multicentric …
S Chiappini, C Cavallotto, A Mosca, F Di Carlo, T Piro… - Pharmaceuticals, 2024 - mdpi.com
Background: Dual disorders (DDs) involve the coexistence of a substance use disorder
(SUD) with another mental illness, often from the psychotic and affective categories. They …
(SUD) with another mental illness, often from the psychotic and affective categories. They …
[HTML][HTML] The patient journey project in Italian mental health services: results from a co-designed survey on clinical interventions and current barriers to improve the …
Introduction The Patient Journey Project aimed to analyze the scenario among Italian Mental
Health Services (MHS) to understand the clinical interventions that are properly …
Health Services (MHS) to understand the clinical interventions that are properly …
Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: A narrative review and recommendation …
Clozapine is the only approved antipsychotic for treatment-resistant schizophrenia (TRS).
Although a large body of evidence supports its efficacy and favorable risk-benefit ratio in …
Although a large body of evidence supports its efficacy and favorable risk-benefit ratio in …
[HTML][HTML] Examining Lurasidone Efficacy in Patients with Schizophrenia Spectrum Illness and Concurrent Alcohol and Substance Use Disorder: A Prospective …
C Cavallotto, S Chiappini, A Mosca, G d'Andrea… - Journal of Clinical …, 2024 - mdpi.com
Background: Dual disorders (DD) entail the coexistence of a substance use disorder (SUD)
and another mental health condition, often within psychotic and affective disorders. This …
and another mental health condition, often within psychotic and affective disorders. This …
Antipsychotic Use and Psychiatric Hospitalization in First-Episode Non-affective Psychosis and Cannabis Use Disorder: A Swedish Nationwide Cohort Study
Abstract Background and Hypothesis There is a paucity of research on treatment outcomes
of patients with psychosis and cannabis use disorder (CUD). We aimed to compare the …
of patients with psychosis and cannabis use disorder (CUD). We aimed to compare the …
Clinical quandaries in psychotic disorders: the road is long, with many a winding turn
S Jauhar, RA McCutcheon - Journal of Psychopharmacology, 2023 - journals.sagepub.com
The author (s) declared the following potential conflicts of interest with respect to the
research, authorship, and/or publication of this article: SJ has received honoraria for non …
research, authorship, and/or publication of this article: SJ has received honoraria for non …